NASDAQ$CCRN
Cross Country Healthcare Inc · Q1 2023 earnings
Q1 2023 earnings · · Investor relations
Briefing
Cross Country Healthcare's first quarter results were announced, revealing revenue and profitability exceeding expectations, driven by strong execution across the business.
Cross Country Healthcare's Q1 2023 results showed revenue of $622.7 million, a net income of $29.4 million, and diluted EPS of $0.81. The company exceeded expectations for revenue and profitability, with physician staffing revenue growing by 75%. They also signed their first Intellify vendor-neutral client contract and repurchased 1.2 million shares of common stock.
- Revenue, Adjusted EBITDA, and Adjusted EPS exceeded guidance ranges.
- Highest revenue quarter in Company history for education and home care.
- Physician Staffing revenue growth of 75% year-over-year.
- First Intellify vendor-neutral client contract signed.
Headline financials
Revenue & EPS history
Cross Country Healthcare · Revenue · Quarterly
$623M
Revenue by segment
Cross Country Healthcare · $623M total across 2 segments · Q1 2023
- Nurse and Allied Staffing$582M-23.9%93.5%
- Physician Staffing$40.4M+74.5%6.5%
Forward guidance
For the second quarter of 2023, Cross Country Healthcare anticipates revenue between $530 million and $540 million, Adjusted EBITDA between $40.0 million and $45.0 million, and Adjusted EPS between $0.55 and $0.65. The company has updated its 2023 annual minimum guidance to at least $2.1 billion in revenue and in excess of $170 million in Adjusted EBITDA.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q1 2023
-2.7%
Avg return
Earnings day
-1.5%
Avg return
5 days after
+0.5%
Avg return
30 days after
44%
28 / 64 earnings
Positive
+24.6%
Q3 2021
Best reaction
-33.6%
Q2 2010
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | +0.8% | +0.4% | +0.8% | |
| Q4 2025 | +8.2% | +7.9% | +0.5% | |
| Q3 2025 | -14.1% | -7.2% | -32.9% | |
| Q1 2025 | +0.4% | +0.8% | -6.7% | |
| Q4 2024 | +0.3% | -6.0% | -13.9% | |
| Q3 2024 | +7.2% | -6.1% | +57.9% | |
| Q2 2024 | -2.7% | -8.2% | -17.3% | |
| Q1 2024 | -4.9% | -9.0% | -14.1% | |
| Q4 2023 | -2.7% | -0.3% | +5.7% | |
| Q3 2023 | -14.0% | -19.0% | -10.7% | |
| Q2 2023 | -14.7% | -14.0% | -3.8% | |
| Q1 2023 | +5.1% | +9.9% | +26.1% | |
| Q4 2022 | -5.6% | +3.2% | -13.2% | |
| Q3 2022 | -2.5% | -11.3% | -2.8% | |
| Q2 2022 | -13.7% | -14.1% | -7.6% | |
| Q1 2022 | -2.6% | -7.1% | +0.9% | |
| Q4 2021 | -1.5% | +6.6% | +2.4% | |
| Q3 2021 | +24.6% | +18.0% | +21.1% | |
| Q2 2021 | +23.0% | +14.6% | +29.7% | |
| Q1 2021 | +16.5% | +24.0% | +17.4% | |
| Q4 2020 | +18.9% | +24.6% | +33.8% | |
| Q3 2020 | -5.0% | -3.0% | +9.3% | |
| Q2 2020 | +9.6% | +4.7% | +1.6% | |
| Q1 2020 | -4.8% | -2.0% | +7.6% | |
| Q4 2019 | +0.4% | -12.2% | -27.7% | |
| Q3 2019 | +14.2% | +16.9% | +10.9% | |
| Q2 2019 | -0.8% | -5.5% | +5.6% | |
| Q1 2019 | +4.7% | +18.7% | +0.9% | |
| Q4 2018 | -3.6% | -11.6% | -22.5% | |
| Q3 2018 | +7.8% | +3.4% | +2.7% | |
| Q2 2018 | -30.9% | -26.0% | -14.7% | |
| Q1 2018 | -16.7% | -11.0% | -4.3% | |
| Q4 2017 | -18.8% | -13.6% | -15.8% | |
| Q3 2017 | -9.6% | -13.8% | -2.6% | |
| Q2 2017 | +3.1% | +1.2% | +2.5% | |
| Q1 2017 | -13.0% | -15.1% | -16.7% | |
| Q4 2016 | +3.4% | -5.3% | -7.2% | |
| Q3 2016 | +22.9% | +24.3% | +31.7% | |
| Q2 2016 | -11.5% | -17.0% | -14.2% | |
| Q1 2016 | +10.0% | — | — | |
| Q4 2015 | -21.9% | — | — | |
| Q3 2015 | +9.5% | — | — | |
| Q2 2015 | +10.1% | — | — | |
| Q1 2015 | -4.6% | — | — | |
| Q4 2014 | -9.6% | — | — | |
| Q3 2014 | -0.5% | — | — | |
| Q2 2014 | +1.8% | — | — | |
| Q1 2014 | -14.3% | — | — | |
| Q4 2013 | -22.3% | — | — | |
| Q3 2013 | +3.1% | — | — | |
| Q2 2013 | -3.3% | — | — | |
| Q1 2013 | +0.4% | — | — | |
| Q4 2009 | -5.5% | — | — | |
| Q3 2012 | -0.9% | — | — | |
| Q2 2012 | -5.5% | — | — | |
| Q1 2011 | -3.1% | — | — | |
| Q1 2012 | +11.8% | — | — | |
| Q4 2011 | +0.8% | — | — | |
| Q3 2010 | +2.5% | — | — | |
| Q3 2011 | +2.5% | — | — | |
| Q2 2011 | -33.6% | — | — | |
| Q4 2010 | -33.6% | — | — | |
| Q2 2010 | -33.6% | — | — | |
| Q1 2010 | -7.9% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro